Why Price Transparency Cannot Cure American Healthcare
Why Price Transparency Cannot Cure American Healthcare Jonathan Klein[*] “Price transparency” is a buzz-phrase one tends to hear a […]
Why Price Transparency Cannot Cure American Healthcare Jonathan Klein[*] “Price transparency” is a buzz-phrase one tends to hear a […]
In this essay, I will assume that it is the day after the Supreme Court’s decision in the upcoming case of King v. Burwell, the latest challenge to the Affordable Care Act, and will further assume that the Supreme Court has found for the plaintiffs in a decision roughly along the lines of that handed down by the DC Circuit panel in Halbig v. Burwell. I will propose and discuss a method that the Obama Administration could use to ensure that the ACA continues to function as intended even after such a ruling, or that the Obama Administration could implement in advance of such a ruling as a means of rendering the King challenge substantively moot. Those familiar with King may wish to skip the “Background” section of this essay, and move directly to the section entitled “Goals and Constraints”.
On Monday, November 10, the Journal on Legislation hosted Professor Steve Ansolabehere (a Harvard government professor who consulted this year
Competitive Ideas for Reducing Healthcare Costs Jeremy Salinger[*] I. Introduction Nino Monea, Class of 2017, recently proposed that making
On this past Election Day, November 4th, hundreds of members of the Harvard Community attended the HLS Election Day party